PYC Therapeutics | PYC - Operating Profit

Stock Price
1.51
Daily Change
-0.01 -0.33%
Monthly
-10.39%
Yearly
25.83%
Q1 Forecast
1.57

PYC Therapeutics reported AUD-13.47M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Medical Developments International AUD -480K 662K Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024